Stealth BioTherapeutics (MITO) Tops Q3 EPS by 1c; Reports Cash and Cash Equivalents of $42.3M

Stealth BioTherapeutics (NASDAQ: MITO) reported Q3 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02).

For earnings history and earnings-related data on Stealth BioTherapeutics (MITO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform